Show simple item record

Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs

dc.contributor.authorColhoun, H M
dc.contributor.authorLivingstone, S J
dc.contributor.authorLooker, H C
dc.contributor.authorMorris, A D
dc.contributor.authorWild, S H
dc.contributor.authorLindsay, R S
dc.contributor.authorReed, C
dc.contributor.authorDonnan, P T
dc.contributor.authorGuthrie, B
dc.contributor.authorLeese, G P
dc.contributor.authorMcKnight, J
dc.contributor.authorPearson, D W M
dc.contributor.authorPearson, E
dc.contributor.authorPetrie, J R
dc.contributor.authorPhilip, Sam
dc.contributor.authorSattar, N
dc.contributor.authorSullivan, F M
dc.contributor.authorMcKeigue, P
dc.contributor.authorScottish Diabetes Research Network (SDRN) Epidemiology group
dc.date.accessioned2016-03-07T12:00:05Z
dc.date.available2016-03-07T12:00:05Z
dc.date.issued2012-11
dc.identifier19894192
dc.identifier4e9575fa-4cea-48cf-a57d-7226731e4c17
dc.identifier22945303
dc.identifier84867571503
dc.identifier.citationColhoun , H M , Livingstone , S J , Looker , H C , Morris , A D , Wild , S H , Lindsay , R S , Reed , C , Donnan , P T , Guthrie , B , Leese , G P , McKnight , J , Pearson , D W M , Pearson , E , Petrie , J R , Philip , S , Sattar , N , Sullivan , F M , McKeigue , P & Scottish Diabetes Research Network (SDRN) Epidemiology group 2012 , ' Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs ' , Diabetologia , vol. 55 , no. 11 , pp. 2929-2937 . https://doi.org/10.1007/s00125-012-2668-0en
dc.identifier.issn1431-0428
dc.identifier.otherORCID: /0000-0001-6164-211X/work/98943068
dc.identifier.urihttp://hdl.handle.net/2164/5619
dc.format.extent9
dc.format.extent194341
dc.language.isoeng
dc.relation.ispartofDiabetologiaen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectfracturesen
dc.subjecthip fractureen
dc.subjectpharmacoepidemiolgyen
dc.subjectthiazolidinedioneen
dc.subjecttype 2 diabetesen
dc.subjectRC Internal medicineen
dc.subject.lccRCen
dc.titleHospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugsen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Rowett Instituteen
dc.contributor.institutionUniversity of Aberdeen.University of Aberdeenen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Grampian Data Safe Haven (DaSH)en
dc.description.statusPeer revieweden
dc.identifier.doi10.1007/s00125-012-2668-0


Files in this item

Thumbnail
Name:
HHF.pdf
Size:
189.7Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record